Literature DB >> 30931535

Idiopathic toxic epidermal necrolysis in an adolescent.

Kathleen F O'Brien1, Rachel E Maiman2,3, Kalyani Marathe3.   

Abstract

A 10-year-old girl, suspected 2 days prior to have streptococcal pharyngitis, presented with diffuse erythema, tense bullae, Nikolsky-positive desquamation, as well as ulcerations of her oral and genital mucosa. She denied recent travel, sick contacts, or preceding and concurrent use of medications, including over-the-counter and herbal supplements. A comprehensive viral polymerase chain reaction (PCR) panel, Mycoplasma pneumoniae PCR and IgM, streptococcal molecular antigen test, urine culture, blood culture, and rheumatologic serologies were negative. Based on the patient's clinical presentation and biopsy results, she was diagnosed with idiopathic toxic epidermal necrolysis.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  idiopathic; pediatrics; toxic epidermal necrolysis

Mesh:

Year:  2019        PMID: 30931535      PMCID: PMC7167717          DOI: 10.1111/pde.13820

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


INTRODUCTION

Stevens‐Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe and potentially fatal mucocutaneous diseases.1 In the United States, the estimated incidence of TEN among children is 0.4/1 000 000 per year.2, 3 Medications and infectious agents are the most common reported causes. We report a challenging diagnosis of TEN with uncertain etiology in a pediatric patient.

CASE

A 10‐year‐old girl initially presented with acute onset of throat pain, fever, rash, and erythematous tonsils with white exudate. She denied the use of any medications, including over‐the‐counter and herbal supplements. There was no history of medication allergies, recent travel, sick contacts, or preceding illness. Oropharyngeal rapid group A streptococcus antigen test was negative, and she was discharged on an empiric course of amoxicillin; however, the prescription was never filled. Two days later, she returned febrile and tachycardic. She had diffuse erythema, tense bullae, and Nikolsky‐positive desquamation covering 80% of her body surface area, as well as severe oral and vaginal mucositis (Figure 1). C‐reactive protein was elevated (22.64 mg/dL, normal <3 mg/dL), and a chest radiograph was consistent with interstitial pneumonia. The remainder of her laboratory workup was normal. Punch biopsies demonstrated subtotal epidermal necrosis with sparse lymphocytic infiltrate on hematoxylin and eosin stain and negative direct immunofluorescence microscopy.
Figure 1

A 10‐y‐old girl with toxic epidermal necrolysis. A, Hemorrhagic crusting of upper and lower vermillion lips with multiple large, tense clear/yellow fluid‐filled bullae on arms and abdomen and Nikolsky‐positive desquamation on abdomen and chest. B, Diffuse desquamation revealing bright pink denuded dermis on the back

A 10‐y‐old girl with toxic epidermal necrolysis. A, Hemorrhagic crusting of upper and lower vermillion lips with multiple large, tense clear/yellow fluid‐filled bullae on arms and abdomen and Nikolsky‐positive desquamation on abdomen and chest. B, Diffuse desquamation revealing bright pink denuded dermis on the back It was initially suspected that her case was infection‐mediated. She was started empirically on azithromycin for possible Mycoplasma pneumoniae–induced rash with mucositis. However, a comprehensive viral respiratory polymerase chain reaction (PCR)1 panel was negative, Chlamydia pneumoniae and M. pneumoniae blood PCR and IgM antibodies were negative on two separate occasions. A second oropharyngeal group A streptococcal molecular antigen test was negative. Two blood cultures and a urine culture demonstrated no bacterial growth. Rowell syndrome (erythema multiforme‐like lesions associated with lupus erythematosus) was ruled out by negative screening tests for a autoimmune disease. With no clear trigger, she was diagnosed with idiopathic TEN. On day 10 of hospitalization, she was transferred to another hospital for escalation of care with 90% body surface area involvement and about 50% total desquamation. Happily, she fully recovered.

DISCUSSION

The incidence of idiopathic SJS and SJS/TEN overlap in the pediatric population is estimated to be 5%‐16.6%.4, 5 Searching for both common and rare causes of SJS/TEN is critically important before identifying a case as idiopathic (Table 1). Often overlooked entities include food ingredients, insecticides, acetaminophen, and herbal remedies.5 Additionally, infectious and autoimmune diseases must be ruled out.
Table 1

Uncommon reported causes of pediatric SJS/TEN

VaccinesHantavirus vaccine
Measles vaccine
Measles, mumps, rubella (MMR) vaccine
Meningococcal B vaccine
Varicella vaccine
Yellow fever vaccine
InsecticidesLambda‐cyhalothrin
Thiamethoxam
Over‐the‐counter medicationsAcetaminophen (eg, paracetamol)
Dimenhydrinate
Multi‐ingredient cold medication
Prescription medicationsBenzodiazepines
Bronchodilator (eg, albuterol)
Chemotherapy agents (eg, methotrexate, dactinomycin, vincristine)
D‐penicillamine
Oral contraceptives
Warfarin
Herbal/Vitamin supplementsAscorbic acid
Ayurvedic drugs
Homeopathic medicines (eg, Chinese herbs)
ProceduresAllogenic hematopoietic stem cell transplantation
Infectious and autoimmune diseases Chlamydia pneumoniae
Graft versus host
Linear IgA bullous dermatosis
Systemic lupus erythematosus
Toxic shock syndrome
Uncommon reported causes of pediatric SJS/TEN In our case, despite the thorough history and workup, an etiology was never found. This suggests that the pathophysiology of SJS/TEN is highly complex and still poorly understood. A patient's predisposition to SJS/TEN is likely multifactorial and an interplay between genetics, the immune system, and environment. An underlying disease process or medication exposure needed to trigger the eruption may not be universal. Idiopathic SJS/TEN is therefore a particular challenge, as the clinical picture alone must guide the clinician toward the most appropriate management, one which optimizes the child's outcome and reduces mortality.
  5 in total

1.  Incidence, outcomes, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  James W Antoon; Jennifer L Goldman; Brian Lee; Alan Schwartz
Journal:  Pediatr Dermatol       Date:  2018-01-09       Impact factor: 1.588

2.  A 15-year review of pediatric toxic epidermal necrolysis.

Authors:  Kevin P Quirke; Anna Beck; Richard L Gamelli; Michael J Mosier
Journal:  J Burn Care Res       Date:  2015 Jan-Feb       Impact factor: 1.845

3.  Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States.

Authors:  Derek Y Hsu; Joaquin Brieva; Nanette B Silverberg; Amy S Paller; Jonathan I Silverberg
Journal:  J Am Acad Dermatol       Date:  2017-03-09       Impact factor: 11.527

4.  Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Associations, Outcomes, and Pathobiology-Thirty Years of Progress but Still Much to Be Done.

Authors:  Robert S Stern; Sherrie J Divito
Journal:  J Invest Dermatol       Date:  2017-05       Impact factor: 8.551

5.  Clinical Features and Treatment Outcomes among Children with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A 20-Year Study in a Tertiary Referral Hospital.

Authors:  Susheera Chatproedprai; Vanvara Wutticharoenwong; Therdpong Tempark; Siriwan Wananukul
Journal:  Dermatol Res Pract       Date:  2018-05-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.